Healthcare101

 The Global Metabolomics Market in terms of revenue was estimated to be worth $1.9 billion in 2020 and is poised to reach $4.1 billion by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, availability of government and private funding for metabolomics research, and ongoing innovations in metabolomics instruments are driving the growth of the global metabolomics industry. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900 Metabolomics Market Dynamics Driver: Availability of government and private funding for metabolomics research Metabolomic studies are gaining prominence in the life science industry as they help rev

  Leukapheresis Market in terms of revenue was estimated to be worth $70 million in 2023 and is poised to reach $100 million by 2028, growing at a CAGR of 8.3 % from 2023 to 2028 according to a new report by MarketsandMarkets™.  The global leukopaks market is anticipated to reach USD 1020 million by 2028 from USD 200 million in 2023, at a CAGR of 38.1%. The leukopaks market is driven by the increasing demand for leukopaks in research applications, such as the development of new cancer treatments. The demand for leukopaks is growing due to the increasing number of research studies being conducted on cancer. The development of new cancer treatments is also driving the demand for leukopaks. Other factors that are contributing to the growth of the leukopaks market include the increasing incidence and prevalence of cancer, the growing popularity of personalized medicine, advances in medical technology, and growing awareness about leukopaks and their benefits in developing nations. Downlo

  Lateral Flow Assays Market in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $16.8 billion by 2029, growing at a CAGR of 7.6% from 2023 to 2029 according to a new report by MarketsandMarkets™. The rising demand of lateral flow assays due to increasing number of geriatric populations, growing prevalence of infectious diseases as well as increasing of point of care tests are some of the key factors that are driving the growth of this market. However, the hesitance in the patients as well as in health professionals to change in the conventional diagnostic method and the lack of accuracy of lateral flow assays are some of the key restraints for lateral flow assays market. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167205133 Browse in-depth TOC on "Lateral Flow Assays Market" 420 - Tables 59 - Figures 399 – Pages "Kits and Reagents segment is expected to witness the highest gro

  Allergy Diagnostics Market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in initiatives and investments for allergy research, growth in home care allergy test kits, and establishment of new facilities by hospitals and clinics. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701 Browse in-depth TOC on "Allergy Diagnostics Market" 248 - Tables 57 - Figures 307 – Pages The consumables segment is expected to account for the largest share in 2023. The Allergy Diagnostics market, by product & service, has been segmented into consumables, instruments, and services. The consumables segment accounted for the largest share of the Allergy Diagnostics market in 2023. This segment is also anticipated to experience s

 According to the new market research report " Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) - Global Forecast to 2025", published by MarketsandMarkets™, is estimated to be USD 5.6 billion in 2020 and projected to reach USD 8.6 billion by 2025, at a CAGR of 9.0%. The Rising target disease population, rapid growth in generic products, rising adoption of self-medication and digitalization, affordable cost with increased efficiency, and technological advancements are the major factors driving the growth of the market. Furthermore, growing initiatives undertaken by leading market players to establish production facilities in both mature and developing markets are the key factors driving the growth of the prefilled syringes industry. Browse and in-depth TOC on " Conventional Prefilled Syringe

  Single Use Assemblies Market in terms of revenue was estimated to be worth $2.5 billion in 2023 and is poised to reach $5.2 billion by 2028, growing at a CAGR of 15.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The global single-use assemblies market is growing owing to factors such as rising adoption of single-use assemblies among startups and SMEs, development and launch of technologically advanced single-use products that offer streamlined workflows, portability, and rapid implementation, and increasing demand for single-use assemblies for R&D and biologics manufacturing. The market growth could be hampered by regulatory concerns and significant concerns regarding extractables and leachables arising from the components of single-use assemblies in bioproduction. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46226549 Browse in-depth TOC on "Single Use Assemblies Market" 235 - Tables 44 - Figure

 The Global Metabolomics Market in terms of revenue was estimated to be worth $1.9 billion in 2020 and is poised to reach $4.1 billion by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, availability of government and private funding for metabolomics research, and ongoing innovations in metabolomics instruments are driving the growth of the global metabolomics industry. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900 Metabolomics Market Dynamics Driver: Availability of government and private funding for metabolomics research Metabolomic studies are gaining prominence in the life science industry as they help rev

 The Global Particle Counters Industry in terms of revenue was estimated to be worth $511 million in 2022 and is poised to reach $826 million by 2027, growing at a CAGR of 10.0% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Favorable conditions and the high adoption of advanced technologies in various medical and industrial sectors have aided the growth of end-use industries for particle counters, such as automotive, aerospace, energy, and oil & gas. Moreover, favorable regulatory scenario, and growing focus on the quality of food products are the key factors driving the growth of this market. In addition, emerging economies (such as Brazil, India, South Korea, and China). Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22156